A part of Watch Media

MedWatchFriday27 January 2023

  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Search
  • Log in
  • Latest
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
09/09/2022at 14:46

Denmark must play role in EU reference lab endgame, says chamber of commerce

The EU will soon make a decision on reference labs required by its new regulation, IVDR. Denmark should be a contender, says the Danish Chamber of Commerce, highlighting benefits.
Photo: LOU BENOIST/AFP / AFP
by andreas lønstrup, translated by daniel pedersen

Distribution of the EU’s reference labs should soon be known.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters

Get full access for you and your coworkers

Start a free company trial today

Related articles:

  • The EU's Medical Device Regulation was a hot topic during Europe's largest annual health and medtech conference, Medtech Forum, which recently took place in May | Photo: PR/Medtech Europe

    Biomedical Alliance Europe warns of potential medical device shortage

    For subscribers

  • Photo: Thomas Borberg

    Long wait for IVDR implementation is over, putting an end to pandemic "wild west"

    For subscribers

  • Serge Bernasconi, CEO of Medtech Europe | Photo: PR/Medtech Europe

    New EU regulation has made the medtech industry turn to the US

    For subscribers

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Foto: Agc Biologics
Pharma & biotech

AGC Biologics to produce Eli Lilly-developed drug delaying type 1 diabetes

The contract manufacturer will produce Tzield, an approved treatment that delays the onset of stage 3 type 1 diabetes, for Provention Bio, which secured rights from Lilly’s partner in 2018.
  • AGC's Japanese and Danish factories to produce German biotech firm's drug candidate
  • AGC Biologics breaks ground on USD 190m Danish factory

For subscribers

Per Wold-Olsen will not seek re-election as GN Group's chair in March | Foto: Mik Eskestad/Jyllands-Posten/Ritzau Scanpix
Hearing health

Per Wold-Olsen's retirement is "a great loss for GN"

For subscribers

Katrine Hammer (right), chief executive officer of Philips Medisize A/S in Denmark and vice president for global innovation and development in Europe | Foto: Phillips-medisize
Medtech

US medtech group expands production in Denmark

For subscribers

Per Wold-Olsen, outgoing chairman of GN's board | Foto: Mik Eskestad
Hearing health

GN's veteran chairman to retire

For subscribers

Jesper J. Lange, co-founder and CEO of MC2 Therapeutics | Foto: Mc2 Therapeutics / Pr
Pharma & biotech

MC2 Therapeutics CEO steps down as board member

For subscribers

Foto: Sebastian Kahnert/AP/Ritzau Scanpix
Pharma & biotech

Atrogi doses first patient in diabetes study

For subscribers

Further reading

Foto: Asensus Surgical/pr
Medtech

Asensus Surgical wins CE Mark for intelligent surgical unit under MDR rules

The EU’s Medical Device Regulation imposes stricter requirements for medical device manufacturers, but the US-based medtech firm still makes it through the regulatory eye of the needle.

For subscribers

Henrik Vestergaard, deputy director at Lif | Foto: Lif / Pr
Pharma & biotech

Pharma association denies pandemic lobbying: "Interest protection was on standby"

Though a new report points to increased pharma lobbying during the pandemic, a Danish trade association says public and private actors came together to solve the crisis in Denmark.

For subscribers

Per Wold-Olsen will not seek re-election as GN Group's chair in March | Foto: Mik Eskestad/Jyllands-Posten/Ritzau Scanpix
Hearing health

Per Wold-Olsen's retirement is "a great loss for GN"

An analyst reacts to the news that GN’s chair is not seeking re-election this year – ”he has been key in helping GN secure a significant position on the hearing aid market.”

For subscribers

Latest news

  • AGC Biologics to produce Eli Lilly-developed drug delaying type 1 diabetes – 26 Jan
  • Per Wold-Olsen's retirement is "a great loss for GN" – 26 Jan
  • US medtech group expands production in Denmark – 26 Jan
  • GN's veteran chairman to retire – 26 Jan
  • MC2 Therapeutics CEO steps down as board member – 26 Jan
  • Atrogi doses first patient in diabetes study – 26 Jan
  • FDA approves ALK's house dust mite tablet for teens – 25 Jan
  • Bavarian Nordic featured on Cowen list of 2023 biotech favorites – 25 Jan
  • Biontech inks deal with UK on sped-up cancer trials – 25 Jan
  • FDA vaccine director flagged concerns over "hyper-accelerated" review of Pfizer's Covid-19 vaccine – 25 Jan
See all

Jobs

  • Application Manager

  • Two department leaders for the Department of Pharmacy and the Department of Drug Design and Pharmacology

  • Application Manager

  • Principal Laboratory Technologist

  • Senior Regulatory Affairs Professional

  • Specialist for the supply of pharmaceuticals to Danish hospitals

  • Sr. Director, Drug Safety Physician

  • Lead Data Architect

  • Head of International Sales

  • Head of Regulatory Affairs Danmark

  • Commercial Director

  • Clinical Operational Associate

See all jobs

Jobs

  • Application Manager

  • Two department leaders for the Department of Pharmacy and the Department of Drug Design and Pharmacology

  • Application Manager

  • Principal Laboratory Technologist

  • Senior Regulatory Affairs Professional

  • Specialist for the supply of pharmaceuticals to Danish hospitals

  • Sr. Director, Drug Safety Physician

  • Lead Data Architect

  • Head of International Sales

  • Head of Regulatory Affairs Danmark

  • Commercial Director

  • Clinical Operational Associate

See all jobs

Colophon

MedWatch
Search

Sections

  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Sitemap
  • RSS feeds

Editor

Mikkel Aabenhus Hemmingsen

mah@medwatch.dk

Tel.: +45 3330 8387

Editor-in-chief

Anders Heering

Publisher

JP/Politiken Media Group Ltd

Advertising

annoncering@infowatch.dk

Tel.: +45 7077 7441

Advertising

Job Advertising

job@infowatch.dk

Tel.: +45 7077 7441

Jobs

Subscription

Try MedWatch or get an offer for a subscription meeting the exact needs of you or your company.

medwatch@infowatch.dk

Tel.: +45 7077 7441

Learn more about subscriptions here

Address

MedWatch

Rådhuspladsen 37

1785 Copenhagen K, Denmark

Tel.: +45 3330 8370

Guidelines

  • Privacy Policy

Copyright © MedWatch — All rights reserved

Microsoft is in the process of discontinuing Internet Explorer – and so are we.
For a better experience, we recommend using one of the following browsers.

Kind regards,
MedWatch

Google ChromeMozilla FirefoxMicrosoft Edge